Description

Algerika (pregabalin) Hard Capsules 75 mg. №56

Composition:

Each hard capsule contains 75 mg of pregabalin.

Mechanism of Action:

Pregabalin binds to calcium channels in the central nervous system, modulating neurotransmitter release and reducing excitability of nerve cells.

Pharmacological Properties:

Pregabalin exerts its effects by affecting neurotransmission in the brain and nervous system, leading to pain relief and anti-seizure activity.

Indications for Use:

Algerika (pregabalin) hard capsules 75 mg. №56 are indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.

Contraindications:

Avoid using Algerika (pregabalin) if you are allergic to pregabalin or any other ingredients in the product. It is contraindicated in patients with heart problems or a history of substance abuse.

Side Effects:

Common side effects may include dizziness, drowsiness, weight gain, and edema. Serious side effects such as allergic reactions or mood changes should be reported to a healthcare provider immediately.

Usage Instructions:

Follow the dosage instructions provided by your healthcare provider. Typically, Algerika is taken orally with or without food, usually twice a day. Do not exceed the recommended dose to prevent adverse reactions.

Benefits Compared to Analogues:

Pregabalin has demonstrated superior efficacy in managing certain neuropathic pain conditions compared to other medications. It also offers a favorable side effect profile for many patients.

Suitable Patient Groups:

Algerika can be prescribed for adults of all ages. However, special caution should be exercised when prescribing to children, elderly patients, or individuals with renal impairment.

Storage and Shelf Life:

Store Algerika in a cool, dry place away from moisture and sunlight. Keep the capsules in their original packaging to protect them from environmental factors. Check the expiration date before use.

Packaging Description:

Algerika (pregabalin) hard capsules are typically packaged in blister packs of 56 capsules each. The packaging should be intact and undamaged when purchased.

Clinical Evidence and Proven Effectiveness:

Pregabalin, the active ingredient in Algerika, has been extensively studied for its efficacy in managing neuropathic pain conditions. Research published in the Journal of Pain Research has shown that pregabalin significantly reduces pain intensity and improves quality of life in patients with diabetic neuropathy.